40 CFR 155.34 – Notice of availability
(a) The Agency will issue in the
(1) Concerns a previously unregistered active ingredient; or
(2) Concerns a previously registered active ingredient, and the Registration Standard states that registrants will be required (under FIFRA section 3(c)(2)(B)) to submit chronic health (including, but not limited to, chronic feeding, oncogenicity and reproduction) or teratology studies.
(b) Interested persons may submit comments concerning any Registration Standard described by paragraph (a) of this section at any time.
(c) The Agency will issue in the